Spearhead Capital Advisors, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History
Spearhead Capital Advisors, LLC
- $92.3 Million
- Q3 2022
A detailed history of Spearhead Capital Advisors, LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Spearhead Capital Advisors, LLC holds 202,580 shares of KNSA stock, worth $5.12 Million. This represents 2.82% of its overall portfolio holdings.
Number of Shares
202,580
Previous 235,024
13.8%
Holding current value
$5.12 Million
Previous $2.28 Million
14.23%
% of portfolio
2.82%
Previous 0.34%
Shares
5 transactions
Others Institutions Holding KNSA
# of Institutions
11Shares Held
1.89MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$38.3 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$997,4160.0% of portfolio
-
Barclays PLC London, X034.8KShares$880,0330.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$757,8000.56% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$730,6200.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $871M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...